ABTCongressional Stock Trades
Abbott Laboratories
Pharmaceutical Preparations
Congressional stock trades in Abbott Laboratories (ABT) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
49
Politicians Trading
19
Last Traded
Jul 30, 2026
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Rick LarsenD | Jul 12, 2026 | Jul 8, 2026 | Sell | $1,001 - $15,000 | +7.81% |
| Ro KhannaD | Jul 6, 2026 | Jun 23, 2026 | Sell | $1,001 - $15,000 | +13.34% |
| Ro KhannaD | Jul 6, 2026 | Jun 23, 2026 | Sell | $1,001 - $15,000 | +13.34% |
| Julie JohnsonD | Jun 12, 2026 | May 12, 2026 | Sell | $1,001 - $15,000 | +21.65% |
| Ro KhannaD | Jun 9, 2026 | May 27, 2026 | Sell | $15,001 - $50,000 | +19.76% |
| Josh GottheimerD | Jun 3, 2026 | May 27, 2026 | Sell | $1,001 - $15,000 | +19.76% |
| Ro KhannaD | May 11, 2026 | Apr 13, 2026 | Sell | $1,001 - $15,000 | +1.91% |
| Gilbert Ray Cisneros, Jr.D | Mar 9, 2026 | Feb 10, 2026 | Sell | $1,001 - $15,000 | -8.61% |
| Julie JohnsonD | Jan 15, 2026 | Dec 18, 2025 | Sell | $1,001 - $15,000 | -17.99% |
| Gilbert Ray Cisneros, Jr.D | Jan 12, 2026 | Dec 19, 2025 | Sell | $1,001 - $15,000 | -18.21% |
| Julie JohnsonD | Dec 11, 2025 | Nov 13, 2025 | Sell | $1,001 - $15,000 | -20.62% |
| Julie JohnsonD | Sep 11, 2025 | Aug 14, 2025 | Sell | $1,001 - $15,000 | -20.63% |
| Josh GottheimerD | Aug 11, 2025 | Jul 18, 2025 | Sell | $1,001 - $15,000 | -17.03% |
| Josh GottheimerD | Apr 10, 2025 | Mar 6, 2025 | Sell | $1,001 - $15,000 | -24.04% |
| Emily RandallD | Feb 11, 2025 | Jan 6, 2025 | Sell | $1,001 - $15,000 | -9.23% |
| Jared MoskowitzD | Feb 10, 2025 | Jan 15, 2025 | Sell | $1,001 - $15,000 | -7.64% |
| Jared MoskowitzD | Feb 10, 2025 | Jan 15, 2025 | Sell | $1,001 - $15,000 | -7.64% |
| Jared MoskowitzD | Feb 10, 2025 | Jan 15, 2025 | Sell | $1,001 - $15,000 | -7.64% |
Price History
About Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.